BellRing Brands Inc. (BRBR) Reached New 2025 Low After Disappointing Earnings
· Stocks · QuoteReporter
BellRing Brands Inc. (BRBR) Post Earning Analysis
BellRing Brands, Inc., founded in 2019 and headquartered in St. Louis, Missouri, is a holding company specializing in nutritional products. The company offers a variety of ready-to-drink protein shakes, other beverages, powders, and nutrition bars under well-known brands like Premier Protein and Dymatize. Its products are widely distributed across multiple channels including club, food, drug, mass, e-commerce, specialty, and convenience stores.
BellRing Brands (BRBR) recently reported its fiscal Q4 earnings, which have shown mixed results, impacting the stock’s performance. The company missed earnings estimates for Q4, while it beat revenue forecasts for Q3 of CY2025. Despite the revenue beat, the stock experienced a significant drop of 16.2% on the same day, highlighting investor concerns. Additionally, BellRing Brands provided an outlook for fiscal year 2026 and updated its long-term financial algorithm, which could influence future stock performance based on investor reactions to the company’s projected growth and operational strategies.
Furthermore, the appointment of David Finkelstein to the Board of Directors could introduce new strategies or changes in governance that might affect the company’s future direction. These developments come at a time when the overall stock market is experiencing a downturn, with indices like the S&P 500 and Dow Jones facing potential losing streaks, adding external market pressures on BellRing Brands’ stock performance.
The price metrics reveal a significant downward trend in the security’s value. The current price of $24.645 reflects a sharp decline of 4.94% today alone. This drop is part of a broader negative trend, as indicated by the substantial discrepancies between the current price and various moving averages: -16.65% from the 20-day MA, -25.62% from the 50-day MA, and a stark -55.05% from the 200-day MA.
Technical indicators reinforce this bearish outlook. An extremely low Relative Strength Index (RSI) of 13.74 indicates severe oversold conditions, which typically suggest a potential for reversal; however, the negative Moving Average Convergence Divergence (MACD) value of -2.24 points to ongoing downward momentum. This combination implies that while a corrective rebound might occur due to oversold conditions, the overall trend remains decisively downward. Investors should be cautious, as the current signals do not yet indicate a stable recovery path.
BellRing Brands, Inc. reported its Q4 and fiscal year 2025 financial results on November 18, 2025. For Q4, the company achieved net sales of $648.2 million, marking a 16.6% increase year-over-year, while annual sales reached $2,316.6 million, up by 16.1%. Despite the growth in sales, both quarterly and annual operating profits declined, with Q4 operating profit at $102.2 million, down 8.8%, and annual operating profit at $357.4 million, a decrease of 7.8%. Net earnings followed a similar trend, decreasing by 16.9% in Q4 to $59.6 million and by 12.3% for the year to $216.2 million.
Adjusted EBITDA saw a slight increase in Q4 to $117.4 million and a more substantial rise of 9.4% annually to $481.6 million. The company generated $260.6 million in cash from operations during the fiscal year and repurchased 9.0 million shares, reflecting a robust share repurchase program.
Key product segments showed mixed results; Premier Protein products experienced significant growth in dollar consumption, whereas Dymatize products saw a slight decline. Looking ahead, BellRing Brands anticipates net sales for the next fiscal year to be between $2.41 billion and $2.49 billion, with an adjusted EBITDA forecast of $425 million to $455 million. The company maintains a long-term financial target of 7% to 9% annual net sales growth and an adjusted EBITDA margin of 18% to 20%.
Earnings Trend Table
| Date | Estimate EPS | Reported EPS | Surprise % | |
|---|---|---|---|---|
| 0 | 2025-11-18 | 0.55 | 0.51 | -6.59 |
| 1 | 2025-05-05 | 0.52 | 0.53 | 1.15 |
| 2 | 2025-02-03 | 0.48 | 0.58 | 21.34 |
| 3 | 2024-11-18 | 0.50 | 0.51 | 2.41 |
| 4 | 2024-08-05 | 0.44 | 0.54 | 21.45 |
| 5 | 2024-05-06 | 0.33 | 0.45 | 34.44 |
| 6 | 2024-02-05 | 0.39 | 0.43 | 10.43 |
| 7 | 2023-11-20 | 0.39 | 0.41 | 4.52 |
Analyzing the EPS trends over the last eight quarters reveals a generally positive performance with a few notable fluctuations. The company has consistently outperformed EPS estimates in six out of the eight quarters, with significant surprises in three instances. Notably, the quarters ending in May 2024 and August 2024 saw substantial EPS beats with surprise percentages of 34.44% and 21.45%, respectively. This suggests a robust operational performance that substantially exceeded analyst expectations during these periods.
Conversely, the most recent quarter ending in November 2025 showed a deviation from this trend, where the company underperformed relative to estimates with a -6.59% surprise. This indicates a potential shift in operational dynamics or market conditions that negatively impacted earnings relative to expectations.
The trend of generally exceeding EPS estimates could signal strong company management and operational efficiency. However, the recent downturn may necessitate closer scrutiny to discern whether it represents a temporary setback or the onset of a more persistent issue. Overall, the historical data portrays a company capable of managing expectations effectively, though with emerging challenges that may need addressing.
The most recent analyst actions on the stock in question show a series of positive adjustments and initiations from various financial firms.
- Bernstein Initiated Coverage (October 23, 2025): Bernstein initiated coverage with an “Outperform” rating and set a target price of $46. This initiation suggests Bernstein’s analysts anticipate the company’s performance to exceed the general expectations of the sector or the standard market performance.
- JP Morgan Resumed Coverage (August 20, 2025): JP Morgan resumed coverage with an “Overweight” rating, assigning a target price of $52. This rating indicates a bullish outlook, implying that JP Morgan analysts expect the stock to outperform either its sector or the broader market.
- Stephens Upgrade (August 6, 2025): Stephens upgraded the stock from “Equal-Weight” to “Overweight” and adjusted the target price to $50. The upgrade reflects a revised expectation that the stock will perform better than previously anticipated, relative to the market or its industry peers.
- DA Davidson Upgrade (May 27, 2025): DA Davidson upgraded their rating from “Neutral” to “Buy” with a significant target price set at $85. This represents the most optimistic target price among the recent ratings, suggesting a strong conviction in the stock’s potential for substantial price appreciation.
Overall, these rating changes reflect a positive shift in sentiment among analysts regarding the stock, with expectations of outperformance and significant price appreciation in the near to mid-term.
As of the current analysis, the stock is trading at $24.65, which is significantly below the average target price set by various analysts. The most recent ratings include a target price of $46 by Bernstein, $52 by JP Morgan, $50 by Stephens, and an optimistic $85 by DA Davidson. These target prices suggest a substantial upside potential from the current trading price, indicating a bullish outlook from the analysts.
Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.